Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)

Clinical trial NCT01305148 · SUSPENDED

Trial details

NCT number: NCT01305148
Sponsor: Iverson Genetic Diagnostics, Inc.
Status: SUSPENDED
Phase: Not Applicable
Study type: INTERVENTIONAL

Anti-coagulation Therapy DVT Pulmonary Embolism Joint Surgery Multiple Atrial Fibrillation Prosthetic Replacement of Mitral Valve

Start date: 2011-08-01
Primary completion: 2015-12-01
Enrollment: 3800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.